Ginkgo biloba:Das Arzneimittelangebot aus pharmazeutischer Sicht*

Journal/Book: Ärztezeitschrift für Naturheilverfahren. 1991; 32/4: 295-303.

Abstract: Apart from the synthesis the increase in the concentration as well as the isolation of plant substances are now as before a source for new drugs. The ginkgolides that are present in the leaves of Ginkgo biloba are selective inhibitors of PAF-induced reactions of the neutrophile granulocytes; the ginkgolides provide new possibilities in the treatment of inflammatory processes and among those above all the inflammatory reactions occurring together with the asthmatic attack. Since about 25 years a fraction of the extract named EGB 761 is used as nootropic drug that is largely free of side-effects. The pharmaceutical quality of the imitator products which are an the market after the expiration of the patients is in part quite different. To be acquainted with the material differences of the various Ginkgo preparations is a prerequisite for the pharmacist to comply with his function as adviser.

Keyword(s): Ginkgo biloba

Zurück | Weiter